jan 1, 2001 - Imatinib Mesylate
Description:
Results of a clinical trial show that the drug imatinib mesylate, which targets a unique protein produced by the Philadelphia chromosome, is effective against chronic myelogenous leukemia (CML). Imatinib treatment changes the usually fatal disease into a manageable condition. Later, it is also shown to be effective in the treatment of gastrointestinal stromal tumors (GIST).Added to timeline:
Date:
jan 1, 2001
Now
~ 25 years ago